Kymera Therapeutics, Inc. - Common Stock (KYMR)
CUSIP: 501575104
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 80,235,145
- Total 13F shares
- 71,721,890
- Share change
- +630,781
- Total reported value
- $2,885,022,540
- Put/Call ratio
- 34%
- Price per share
- $40.23
- Number of holders
- 177
- Value change
- +$14,409,751
- Number of buys
- 79
- Number of sells
- 88
Quarterly Holders Quick Answers
What is CUSIP 501575104?
CUSIP 501575104 identifies KYMR - Kymera Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501575104:
Top shareholders of KYMR - Kymera Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
8.3%
|
6,645,474
|
$314,531,000 | — | 30 Sep 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
7.5%
|
5,995,929
|
$283,787,320 | — | 30 Sep 2024 | |
| BVF INC/IL |
13F
|
Company |
6.4%
|
5,161,801
|
$244,308,041 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
6.4%
|
5,109,141
|
$241,815,645 | — | 30 Sep 2024 | |
| Atlas Venture Fund X, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,504,905
|
$235,830,130 | — | 11 Mar 2024 | |
| Atlas Venture Life Science Advisors, LLC |
13F
|
Company |
6.1%
|
4,896,462
|
$231,749,546 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.9%
|
4,753,766
|
$224,995,745 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.8%
|
4,618,359
|
$218,586,931 | — | 30 Sep 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
5.6%
|
4,500,000
|
$212,985,000 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
5.2%
|
4,211,649
|
$199,337,348 | — | 30 Sep 2024 | |
| ATLAS VENTURE ASSOCIATES X, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,763,012
|
$173,161,222 | — | 11 Aug 2021 | |
| Siren, L.L.C. |
13F
|
Individual |
3.7%
|
2,969,733
|
$140,557,463 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
1,728,144
|
$81,793,056 | — | 30 Sep 2024 | |
| Redmile Group, LLC |
13F
|
Company |
1.7%
|
1,393,256
|
$65,942,806 | — | 30 Sep 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.7%
|
1,328,703
|
$62,887,513 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,053,224
|
$49,858,499 | — | 30 Sep 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.3%
|
1,049,386
|
$49,667,439 | — | 30 Sep 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.99%
|
797,681
|
$37,754,243 | — | 30 Sep 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
0.75%
|
600,326
|
$28,413,430 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.65%
|
525,094
|
$24,852,699 | — | 30 Sep 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.63%
|
507,902
|
$24,039,002 | — | 30 Sep 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.62%
|
500,000
|
$23,665,000 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.61%
|
488,077
|
$23,100,699 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.59%
|
472,626
|
$22,374,134 | — | 30 Sep 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.57%
|
453,377
|
$21,458,333 | — | 30 Sep 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
0.56%
|
450,000
|
$21,298,500 | — | 30 Sep 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.53%
|
428,529
|
$20,282,278 | — | 30 Sep 2024 | |
| Deer Management Co. LLC |
13F
|
Company |
0.52%
|
415,895
|
$19,684,310 | — | 30 Sep 2024 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.51%
|
406,348
|
$19,232,451 | — | 30 Sep 2024 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.49%
|
392,263
|
$18,565,808 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.48%
|
384,175
|
$18,183,002 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.46%
|
366,841
|
$17,362,585 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.42%
|
336,300
|
$15,917,079 | — | 30 Sep 2024 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.36%
|
291,340
|
$13,789,122 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.34%
|
270,035
|
$12,780,757 | — | 30 Sep 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.29%
|
234,771
|
$11,111,711 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.28%
|
224,831
|
$10,641,251 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.27%
|
217,619
|
$10,299,908 | — | 30 Sep 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.26%
|
206,894
|
$10,073,669 | — | 30 Sep 2024 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
0.26%
|
208,743
|
$9,879,806 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.23%
|
188,197
|
$8,907,365 | — | 30 Sep 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.22%
|
179,186
|
$8,480,870 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.2%
|
163,919
|
$7,758,287 | — | 30 Sep 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.18%
|
143,692
|
$6,996,363 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.18%
|
140,491
|
$6,649,439 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.17%
|
140,187
|
$6,635,050 | — | 30 Sep 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.16%
|
128,267
|
$6,070,877 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.16%
|
124,614
|
$5,897,981 | — | 30 Sep 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.15%
|
123,045
|
$5,823,719 | — | 30 Sep 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.15%
|
122,090
|
$5,778,520 | — | 30 Sep 2024 |
Institutional Holders of Kymera Therapeutics, Inc. - Common Stock (KYMR) as of Q4 2024
As of 31 Dec 2024,
Kymera Therapeutics, Inc. - Common Stock (KYMR) was held by
177 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,721,890 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, BVF INC/IL, Avoro Capital Advisors LLC, Atlas Venture Life Science Advisors, LLC, VANGUARD GROUP INC, FMR LLC, BlackRock, Inc., and Siren, L.L.C..
This page lists
177
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
174
Q4 2024 holders
177
Holder diff
3
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.